NxStage Announces Third Quarter 2011 Investor Conference Schedule

LAWRENCE, Mass., Aug 5, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert Brown, Chief Financial Officer, will participate in the following schedule of investor conferences.  A webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of each conference.  

(Logo:  http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

Lazard Capital Markets 2nd Annual Medical Technology Corporate Access Day

Peninsula Hotel, Chicago, IL

Tuesday, Aug. 9, 2011


2011 Canaccord Genuity Growth Conference
Intercontinental Boston, Boston MA

Wednesday, Aug. 10, 2011
9:00 a.m. ET


Rodman & Renshaw Annual Global Investment Conference

The Waldorf-Astoria, New York, NY

September 11-13, 2011


Jefferies 2011 Global Healthcare Conference

The Waldorf Hilton, London, UK

September 27-28, 2011



About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Messrs. Burbank and Brown's plans to present at these conferences.  NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.

Contact:

Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com

SOURCE NxStage Medical, Inc.



RELATED LINKS
http://www.nxstage.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.